Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 12Solid Tumor 9Solid Tumors 6Advanced Solid Tumors 5Advanced Solid Tumor 4Advanced Solid Tumour 2Solitary Fibrous Tumor, Pleural 1Solid Tumor Cancer 1Resectable Colon Cancer 1Mesothelioma, Malignant 1MSI-H Colorectal Cancer 1Locally Advanced and Metastatic Solid Tumors 1DMMR Colorectal Cancer 1Childhood Solid Tumor 1Advanced Solid Tumor Cancer 1Advanced Malignant Solid Tumors 1Adult 1

Interventions

Cisplatin 57Pemetrexed 46pembrolizumab 18Nivolumab 15Carboplatin 15Gemcitabine 14Cyclophosphamide 13Radiotherapy 10Drug Therapy 9atezolizumab 8Platinum 7Ipilimumab 7Doxorubicin 7durvalumab 61,2-diaminocyclohexaneplatinum II citrate 6tremelimumab 5sodium thiosulfate 5Vinorelbine 5Radiotherapy, Intensity-Modulated 5Interleukin-2 5Chemotherapy, Adjuvant 5Cerebral Decortication 5sargramostim 4fludarabine 4defactinib 4aldesleukin 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3cediranib 3Photochemotherapy 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Capecitabine × Other solid neoplasm × Clear all
NCT00004183 2016-07-14

Capecitabine in Treating Patients With Malignant Mesothelioma

Alliance for Clinical Trials in Oncology

Phase 2 Completed
27 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡